News
1 October 2026
Fonko Strengthens Indonesia’s Oncology Industry Capacity
JAKARTA — PT Fonko International Pharmaceuticals has recorded several key milestones in the development of oncology drug manufacturing in Indonesia. These achievements include securing European Union Good Manufacturing Practice (EU GMP) certification in 2025, developing a range of "first copy" products for cancer therapy, and obtaining halal certification for its…
25 September 2026
Consistently Maintaining Halal Standards, Dexa Group Wins IHYA 2026
TANGERANG — PT Ferron Par Pharmaceuticals, a member of Dexa Group, has won the 2026 Indonesia Halal Industry Award (IHYA) from the Ministry of Industry of the Republic of Indonesia in the Large Industrial Enterprise Category, Subcategory of Best Pharmaceuticals and Traditional Medicines. This award recognizes Dexa Group’s consistency in…
24 September 2026
From Medications to Facilities, Ferron Strengthens Support for Cancer Patients
JAKARTA — Indonesia recorded 474,083 new cases and 283,299 deaths due to cancer, according to 2024 Global Cancer Observatory (GLOBOCAN) data. This situation underscores the critical role of Ferron Par Pharmaceuticals in expanding its support for cancer patients—from delivering access to medications to strengthening chemotherapy support facilities through the provision…
11 May 2018
Dexa Medica Wins IMACO 2018
PT Dexa Medica has been awarded as the Innovative Company in Pharmaceutical Sector at the Indonesia Most Admired Companies (IMACO) Award 2018—becoming the only pharmaceutical company to receive the award. According to research conducted by Warta Ekonomi Research and Consulting (WERC), the company scored the highest brand awareness and the…
3 May 2018
Ferron Wins “The Outstanding Corporate Innovator Award 2018”
PT Ferron Par Pharmaceuticals at The 4th Outstanding Corporate Innovator (OCI) Award 2018 won the 2018 Platinum Award, Shangri-la Hotel, Jakarta, on Wednesday, April 2 2018. The award was given by the Executive Director of PPM Manajemen Bramantyo Djohanputro to the President Director of PT Ferron Par Pharmaceuticals Krestijanto Pandji.…
26 April 2018
Vice President of Indonesia Presented WIPO Award 2018 to DLBS Executive Director
Dexa Laboratories of Biomolecular Sciences (DLBS) Executive Director, Raymond R Tjandrawinata, Ph.D., MS, MBA has been awarded a WIPO Medal for Inventors at the World Intellectual Property Organization (WIPO) Award 2018 held in the Vice Presidential Palace on Thursday, 26 April 2018. This award was presented directly by the Vice…
20 April 2018
Dexa Medica Receives First Acknowledgement for the Year 2018
Dexa Medica received another Certificate of Appreciation for the third time through its CSR activities in West Java implemented throughout 2017. The company received not only the certificate but also an award plaque for its sustainable health education program in 13 villages which has been running since 2016 in collaboration…
8 December 2017
The Indonesia Most Admired CEO Award for Dexa Group CEO
Dexa Group CEO, Ir. Ferry A. Soetikno, MSc., MBA., received the Indonesia Most Admired CEO Award as the Visionary in Pharmacy Sector. This award is given on Friday, December 8, 2017 at Rafflesia Grand Ballroom Balai Kartini, Jakarta. The Indonesia Most Admired CEO Award 2017 was handed by the Coordinating…
23 November 2017
First in Indonesia Award for HerbaPAIN
HERBAPAIN was recognized as the first product in Indonesia in the Herbal Headache Medicine Category. This recognition was given by an independent research institution to HERBAPAIN through a survey and considered successful to invent a new product innovation in the past year. Pertama di Indonesia (First in Indonesia), is an…
22 November 2017
PT Ferron Par Pharmaceuticals a Dexa Group Company Achieved The Primaniyarta Award 2017
PT Ferron Par Pharmaceuticals, one of a Dexa Group company, achieved the Primaniyarta Award 2017 in the category of the New Market Pioneer. The award was granted by the President of the Republic of Indonesia, Ir. H. Joko Widodo to the President Director of PT Ferron Par Pharmaceuticals, Krestijanto Pandji,…